010783020	010783020	CD	B-NP	O
|	|	NN	I-NP	O
CEMH	CEMH	NN	I-NP	O
|	|	NN	I-NP	O
09823070	09823070	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5840580	5840580	CD	B-NP	O
|	|	CC	I-NP	O
10/25/2007	10/25/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
intraabdominal	intraabdominal	JJ	I-NP	O
abscess	abscess	NN	I-NP	O
|	|	NN	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/25/2007	9/25/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/14/2007	3/14/2007	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
BOTTINI	BOTTINI	NNP	B-NP	O
,	,	,	O	O
CARROL	CARROL	NNP	B-NP	O
MD	MD	NNP	I-NP	O
PRIMARY	PRIMARY	NNP	I-NP	O
CARE	CARE	NNP	I-NP	O
PHYSICIAN	PHYSICIAN	NNP	I-NP	O
:	:	:	O	O
Noel	Noel	NNP	B-NP	O
Botterbusch	Botterbusch	NNP	I-NP	O
,	,	,	O	O
MD	MD	NNP	B-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
Nyla	Nyla	NNP	B-NP	O
General	General	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Surgery	Surgery	NNP	I-NP	O
.	.	.	O	O

PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Wound	Wound	JJ	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

LIST	LIST	NN	B-NP	O
OF	OF	IN	B-PP	O
PROBLEMS	PROBLEMS	NNP	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Wound	Wound	JJ	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Asthma	Asthma	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Obstructive	Obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Morbid	Morbid	JJ	B-NP	O
obesity	obesity	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Depression	Depression	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Peripheral	Peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
cerebrovascular	cerebrovascular	JJ	B-NP	O
accident	accident	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
51-year-old	51-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
recurrent	recurrent	JJ	B-NP	O
incisional	incisional	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	B-protein
post	post	NN	I-NP	I-protein
repair	repair	NN	I-NP	I-protein
x2	x2	NN	I-NP	I-protein
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Beaston	Beaston	NNP	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
now	now	RB	B-ADVP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
five	five	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
fever	fever	NN	B-NP	O
to	to	TO	B-PP	O
103	103	CD	B-NP	O
,	,	,	O	O
vomiting	vomit	VBG	B-VP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
dizziness	dizziness	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
constipation	constipation	NN	B-NP	O
or	or	CC	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
,	,	,	O	O
urinary	urinary	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
and	and	CC	O	O
nausea	nausea	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pain	pain	NN	I-NP	O
is	be	VBZ	B-VP	O
constant	constant	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
sharp	sharp	JJ	I-ADJP	O
over	over	IN	B-PP	O
her	her	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
incision	incision	NN	I-NP	O
.	.	.	O	O

Last	Last	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
movement	movement	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
PCI	PCI	NN	I-NP	O
in	in	IN	B-PP	O
2003	2003	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
,	,	,	O	O
insulin-dependant	insulin-dependant	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
cerebrovascular	cerebrovascular	JJ	B-NP	O
accident	accident	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
detail	detail	NN	B-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
thalamic	thalamic	JJ	I-NP	O
infarct	infarct	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
temporal	temporal	JJ	B-NP	O
watershed	watershe	VBN	B-VP	O
with	with	IN	B-PP	O
residual	residual	JJ	B-NP	O
right-sided	right-sided	JJ	I-NP	O
weakness	weakness	NN	I-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	IN	B-PP	O
right	right	JJ	B-NP	O
saphenous	saphenous	JJ	I-NP	O
artery	artery	NN	I-NP	O
stent	stent	NN	I-NP	O
,	,	,	O	O
GERD	GERD	NN	B-NP	O
,	,	,	O	O
gastritis	gastritis	NN	B-NP	O
,	,	,	O	O
erosive	erosive	JJ	B-NP	O
esophagitis	esophagitis	NN	I-NP	O
,	,	,	O	O
asthma	asthma	NN	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
FEV	FEV	NN	I-NP	O
of	of	IN	B-PP	O
2.2	2.2	CD	B-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
FEV-FVC	FEV-FVC	JJ	I-NP	O
ratio	ratio	NN	I-NP	O
of	of	IN	B-PP	O
82	82	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
sleep	sleep	NN	B-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
morbid	morbid	NN	B-NP	O
obesity	obesity	NN	I-NP	O
,	,	,	O	O
currently	currently	RB	B-ADVP	O
undergoing	undergo	VBG	B-VP	O
outpatient	outpatient	NN	B-NP	O
evaluation	evaluation	NN	I-NP	O
for	for	IN	B-PP	O
gastric	gastric	JJ	B-NP	O
bypass	bypass	NN	I-NP	O
surgery	surgery	NN	I-NP	O
,	,	,	O	O
depression	depression	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
fibromyalgia	fibromyalgia	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NN	B-NP	O
SURGICAL	SURGICAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Cholecystectomy	Cholecystectomy	NN	B-NP	O
;	;	:	O	O
repair	repair	NN	B-NP	O
of	of	IN	B-PP	O
ventral	ventral	JJ	B-NP	B-protein
hernias	hernia	NNS	I-NP	I-protein
x2	x2	NN	I-NP	I-protein
,	,	,	O	O
last	last	JJ	B-NP	O
one	one	CD	I-NP	O
in	in	IN	B-PP	O
2001	2001	CD	B-NP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Ebert	Ebert	NNP	I-NP	O
;	;	:	O	O
total	total	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
hysterectomy	hysterectomy	NN	I-NP	O
,	,	,	O	O
oophorectomy	oophorectomy	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
tubal	tubal	JJ	B-NP	O
ligation	ligation	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
AT	AT	NN	I-NP	O
HOME	HOME	NN	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	B-protein
inhaler	inhaler	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
puffs	puff	VBZ	B-VP	O
four	four	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
,	,	,	O	O
amitriptyline	amitriptyline	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Lipitor	Lipitor	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Caltrate	Caltrate	NNP	B-NP	O
600	600	CD	I-NP	O
plus	plus	CC	O	O
D	D	NN	B-NP	O
one	one	CD	I-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Diltiazem	Diltiazem	NNP	B-NP	O
sustained	sustain	VBD	B-VP	O
release	release	NN	B-NP	O
120	120	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Nexium	Nexium	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
daily	daily	JJ	I-NP	O
,	,	,	I-NP	O
ferrous	ferrous	JJ	I-NP	O
sulfate	sulfate	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Prozac	Prozac	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Advair	Advair	NNP	B-NP	O
Diskus	Diskus	NNP	I-NP	O
550	550	CD	I-NP	O
one	one	CD	I-NP	O
puff	puff	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
glyburide	glyburide	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
hydrochlorothiazide	hydrochlorothiazide	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
NPH	NPH	NN	I-NP	I-protein
Humulin	Humulin	NN	I-NP	I-protein
70	70	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	O
every	every	DT	B-NP	O
morning	morning	NN	I-NP	O
,	,	,	O	O
60	60	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
every	every	DT	B-NP	O
evening	evening	NN	I-NP	O
,	,	,	O	O
Insulin	Insulin	NNP	B-NP	B-protein
Regular	Regular	NNP	I-NP	I-protein
Humulin	Humulin	NNP	I-NP	I-protein
5	5	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	O
every	every	DT	B-NP	O
morning	morning	NN	I-NP	O
,	,	,	O	O
Insulin	Insulin	NNP	B-NP	B-protein
Regular	Regular	NNP	I-NP	I-protein
Humulin	Humulin	NNP	I-NP	I-protein
80	80	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	O
a.c.	a.c.	RB	I-ADVP	O
,	,	,	O	O
Imdur	Imdur	NN	B-NP	O
ER	ER	NN	I-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
oxycodone	oxycodone	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
every	every	DT	B-NP	O
six	six	CD	I-NP	O
hours	hour	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
34-pack-year	34-pack-year	JJ	I-NP	O
smoker	smoker	NN	I-NP	O
that	that	WDT	B-NP	O
quit	quit	VBD	B-VP	O
one	one	CD	B-NP	O
year	year	NN	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
ETOH	ETOH	NN	I-NP	O
or	or	CC	O	O
IV	IV	CD	B-NP	O
drug	drug	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
abdomen	abdomen	NN	I-NP	O
was	be	VBD	B-VP	O
both	both	CC	O	O
soft	soft	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
obese	obese	JJ	I-ADJP	O
.	.	.	O	O

Tender	Tender	NN	B-NP	O
above	above	IN	B-PP	O
the	the	DT	B-NP	O
midline	midline	NN	I-NP	O
incision	incision	NN	I-NP	O
with	with	IN	B-PP	O
induration	induration	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
overlying	overlie	VBG	I-NP	O
erythema	erythema	NN	I-NP	O
.	.	.	O	O

LABS	LABS	NN	B-NP	B-protein
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
high	high	JJ	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
20.5	20.5	CD	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
troponin	troponin	NN	I-NP	O
of	of	IN	B-PP	O
0.16	0.16	CD	B-NP	O
.	.	.	O	O

Imaging	Imaging	NN	B-NP	O
:	:	:	O	O
CT	CT	NN	B-NP	O
scan	scan	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
abdomen	abdomen	NN	I-NP	O
and	and	CC	I-NP	O
pelvis	pelvis	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
6.1	6.1	CD	I-NP	O
x	x	SYM	I-NP	O
6-cm	6-cm	NN	I-NP	O
loculated	loculate	VBN	I-NP	O
abscess	abscess	NN	I-NP	O
adjacent	adjacent	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
current	current	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
,	,	,	O	O
not	not	RB	O	O
communicating	communicate	VBG	B-VP	O
with	with	IN	B-PP	O
small	small	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
obstruction	obstruction	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Istsa	Istsa	NNP	I-NP	O
Anyi	Anyi	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
Surgery	Surgery	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
reviewing	review	VBG	B-VP	O
once	once	RB	B-ADVP	O
more	more	JJR	I-ADVP	O
the	the	DT	B-NP	O
imaging	imaging	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
abscess	abscess	NN	I-NP	O
was	be	VBD	B-VP	O
involving	involve	VBG	I-VP	O
the	the	DT	B-NP	O
mesh	mesh	NN	I-NP	O
placed	place	VBN	B-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
ventral	ventral	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
repair	repair	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
decision	decision	NN	I-NP	O
to	to	TO	B-VP	O
proceed	proceed	VB	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
Interventional	Interventional	JJ	I-NP	O
Radiology	Radiology	NN	I-NP	O
guided	guide	VBD	B-VP	O
percutaneous	percutaneous	JJ	B-NP	O
drainage	drainage	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
abscess	abscess	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
.	.	.	O	O

98	98	CD	B-NP	O
mL	mL	NN	I-NP	O
of	of	IN	B-PP	O
dark	dark	JJ	B-NP	O
brown	brown	JJ	I-NP	O
and	and	CC	I-NP	O
bloody	bloody	JJ	I-NP	O
discharge	discharge	NN	I-NP	O
was	be	VBD	B-VP	O
extruded	extrude	VBN	I-VP	O
from	from	IN	B-PP	O
this	this	DT	B-NP	O
procedure	procedure	NN	I-NP	O
and	and	CC	O	O
sent	send	VBN	B-VP	O
to	to	TO	B-PP	O
microbiology	microbiology	NN	B-NP	O
,	,	,	O	O
two	two	CD	B-NP	O
drains	drain	NNS	I-NP	O
were	be	VBD	B-VP	O
left	leave	VBN	I-VP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
.	.	.	O	O

Eventually	Eventually	RB	B-ADVP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
Klebsiella	Klebsiella	NN	I-NP	O
pneumoniae	pneumoniae	NNS	I-NP	O
grew	grow	VBD	B-VP	O
sensitive	sensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
several	several	JJ	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
her	her	PRP$	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
was	be	VBD	B-VP	O
redirected	redirect	VBN	I-VP	O
to	to	TO	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
10/2/07	10/2/07	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
to	to	TO	B-VP	O
remove	remove	VB	I-VP	O
the	the	DT	B-NP	O
infected	infected	JJ	I-NP	O
mesh	mesh	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
Cardiology	Cardiology	NNP	I-NP	O
consult	consult	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
obtained	obtain	VBN	I-VP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
her	her	PRP$	B-NP	O
troponin	troponin	NN	I-NP	O
leak	leak	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
event	event	NN	I-NP	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
ischemic	ischemic	JJ	B-ADJP	O
in	in	IN	B-PP	O
nature	nature	NN	B-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
given	give	VBN	B-PP	O
her	her	PRP$	B-NP	O
surgical	surgical	JJ	I-NP	O
indication	indication	NN	I-NP	O
,	,	,	O	O
Cardiology	Cardiology	NNP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
recommend	recommend	VB	I-VP	O
an	an	DT	B-NP	O
intervention	intervention	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Cath	Cath	NNP	I-NP	O
Lab	Lab	NNP	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
moment	moment	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
they	they	PRP	B-NP	O
do	do	VBP	B-VP	O
recommend	recommend	VB	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
followed	follow	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
wound	wound	NN	I-NP	O
exploration	exploration	NN	I-NP	O
and	and	CC	I-NP	O
removal	removal	NN	I-NP	O
of	of	IN	B-PP	O
mesh	mesh	NN	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEMS	SYSTEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
with	with	IN	B-PP	O
p.r.n.	p.r.n.	NN	B-NP	O
morphine	morphine	NN	I-NP	O
and	and	CC	O	O
eventually	eventually	RB	B-ADVP	O
p.r.n.	p.r.n.	NN	B-NP	O
oxycodone	oxycodone	NN	I-NP	O
to	to	TO	B-VP	O
control	control	VB	I-VP	O
her	her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
depression	depression	NN	B-NP	O
,	,	,	O	O
so	so	IN	O	O
a	a	DT	B-NP	O
Social	Social	NNP	I-NP	O
Work	Work	NNP	I-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
provided	provide	VBD	B-VP	O
emotional	emotional	JJ	B-NP	O
support	support	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
given	give	VBN	I-VP	O
IV	IV	CD	B-NP	O
Lopressor	Lopressor	NN	I-NP	O
perioperatively	perioperatively	RB	B-ADVP	O
and	and	CC	I-ADVP	O
eventually	eventually	RB	I-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

Cardiology	Cardiology	NNP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
troponin	troponin	NN	I-NP	O
trended	trend	VBD	B-VP	O
down	down	RB	B-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
diet	diet	NN	I-NP	O
was	be	VBD	B-VP	O
going	go	VBG	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
advanced	advance	VBN	I-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
unfortunately	unfortunately	RB	B-NP	O
bile	bile	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
seeping	seep	VBG	I-VP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
abdominal	abdominal	JJ	I-NP	O
wound	wound	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
interpreted	interpret	VBN	I-VP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
an	an	DT	B-NP	O
enterocutaneous	enterocutaneous	JJ	I-NP	O
fistula	fistula	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
bowel	bowel	NN	B-NP	O
rest	rest	NN	I-NP	O
and	and	CC	O	O
wet-to-dry	wet-to-dry	JJ	B-NP	O
dressings	dressing	NNS	I-NP	O
initially	initially	RB	B-ADVP	O
.	.	.	O	O

Eventually	Eventually	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
VAC	VAC	NN	I-NP	O
sponge	sponge	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
after	after	IN	B-PP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
was	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
and	and	CC	O	O
healthy	healthy	JJ	B-NP	O
granulation	granulation	NN	I-NP	O
tissue	tissue	NN	I-NP	O
was	be	VBD	B-VP	O
appreciated	appreciate	VBN	I-VP	O
underneath	underneath	IN	B-PP	O
its	its	PRP$	B-NP	O
original	original	JJ	I-NP	O
place	place	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
new	new	JJ	I-NP	O
VAC	VAC	NN	I-NP	O
sponge	sponge	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
placed	place	VBN	I-VP	O
once	once	RB	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	I-VP	O
rehab	rehab	VB	I-VP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

GU	GU	NN	B-NP	O
:	:	:	O	O
Maintenance	Maintenance	NNP	B-NP	O
IVF	IVF	NNP	I-NP	O
as	as	IN	B-PP	O
needed	need	VBN	B-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
PICC	PICC	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
and	and	CC	O	O
TPN	TPN	NN	B-NP	B-protein
was	be	VBD	B-VP	O
initiated	initiate	VBN	I-VP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
enterocutaneous	enterocutaneous	JJ	I-NP	O
fistula	fistula	NN	I-NP	O
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
.	.	.	O	O

TPN	TPN	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
now	now	RB	B-ADVP	O
at	at	IN	B-PP	O
goal	goal	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
Subcutaneous	Subcutaneous	JJ	B-NP	O
heparin	heparin	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
:	:	:	O	O
Diabetes	Diabetes	NNP	B-NP	O
Service	Service	NNP	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
a	a	DT	B-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	B-ADJP	O
difficult	difficult	JJ	I-ADJP	O
to	to	TO	B-VP	O
achieve	achieve	VB	I-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
high	high	JJ	B-NP	O
blood	blood	NN	I-NP	O
glucose	glucose	NN	I-NP	O
measurements	measurement	NNS	I-NP	O
initially	initially	RB	B-ADVP	O
and	and	CC	O	O
brief	brief	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
hypoglycemia	hypoglycemia	NN	B-NP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
before	before	IN	B-PP	O
her	her	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
now	now	RB	B-ADVP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
optimal	optimal	JJ	B-ADJP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
Initially	Initially	RB	B-ADVP	O
received	receive	VBD	B-VP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Flagyl	Flagyl	NN	B-NP	O
since	since	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
once	once	RB	B-ADVP	O
the	the	DT	B-NP	O
above	above	JJ	I-NP	O
results	result	NNS	I-NP	O
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
,	,	,	O	O
this	this	DT	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
tailored	tailor	VBN	I-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
now	now	RB	I-VP	O
being	be	VBG	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
no	no	DT	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATION	MEDICATION	NN	I-NP	O
:	:	:	O	O
Tylenol	Tylenol	NN	B-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
4	4	CD	I-NP	O
h.	h.	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
headache	headache	NN	B-NP	O
or	or	CC	I-NP	O
fever	fever	NN	I-NP	O
to	to	TO	B-PP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
101	101	CD	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
nebulizer	nebulizer	NN	I-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
nebs	neb	NNS	I-NP	O
every	every	DT	B-NP	O
four	four	CD	I-NP	O
hours	hour	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
amitriptyline	amitriptyline	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
insomnia	insomnia	NN	B-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Diltiazem	Diltiazem	NNP	B-NP	O
Extended	Extended	NNP	I-NP	O
Release	Release	NNP	I-NP	O
120	120	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Prozac	Prozac	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Advair	Advair	NNP	B-NP	O
Diskus	Diskus	NNP	I-NP	O
550	550	CD	I-NP	O
one	one	CD	I-NP	O
puff	puff	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
heparin	heparin	NN	B-NP	B-protein
5000	5000	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-NP	O
every	every	DT	I-NP	O
eight	eight	CD	I-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
NPH	NPH	NN	I-NP	I-protein
Humulin	Humulin	NN	I-NP	I-protein
25	25	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
every	every	DT	B-NP	O
morning	morning	NN	I-NP	O
and	and	CC	O	O
25	25	CD	B-NP	O
units	unit	NNS	I-NP	O
every	every	DT	B-NP	O
evening	evening	NN	I-NP	O
,	,	,	O	O
Insulin	Insulin	NN	B-NP	B-protein
Regular	Regular	JJ	I-NP	I-protein
Humulin	Humulin	NN	I-NP	I-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
every	every	DT	B-NP	O
four	four	CD	I-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
Imdur	Imdur	NN	B-NP	O
ER	ER	NN	I-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-NP	O
twice	twice	RB	I-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
naftifine	naftifine	NN	B-NP	O
topical	topical	JJ	I-NP	O
daily	daily	NN	I-NP	O
,	,	,	O	O
octreotide	octreotide	NN	B-NP	O
acetate	acetate	NN	I-NP	O
100	100	CD	I-NP	O
mcg	mcg	NN	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
twice	twice	RB	I-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
oxycodone	oxycodone	NN	B-NP	O
5	5	CD	I-NP	O
to	to	TO	I-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
every	every	DT	B-NP	O
four	four	CD	I-NP	O
hours	hour	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
simvastatin	simvastatin	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
Rehabilitation	Rehabilitation	NN	B-NP	O
facility	facility	NN	I-NP	O
.	.	.	O	O

FOLLOWUP	FOLLOWUP	NN	B-NP	O
PLANS	PLANS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
contact	contact	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Waldhauser	Waldhauser	NNP	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
followup	followup	NN	I-NP	O
appointment	appointment	NN	I-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
2-1778561	2-1778561	CD	B-NP	O
CSSten	CSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
FREIMAN	FREIMAN	NNP	B-NP	O
,	,	,	O	O
PATRICIA	PATRICIA	NNP	B-NP	O
TUAN	TUAN	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
GLASER	GLASER	NN	B-NP	O
,	,	,	O	O
MARTY	MARTY	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
0598600	0598600	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
4/7/07	4/7/07	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
4/7/07	4/7/07	CD	B-NP	O

